Effective Tumor Debulking With Ibrutinib Lead-In Before Venetoclax Initiation in CLL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effective Tumor Debulking With Ibrutinib Before Initiation of Venetoclax: Results From the CAPTIVATE Minimal Residual Disease (MRD) and Fixed-Duration (FD) Cohorts
Clin. Cancer Res 2022 Aug 08;[EPub Ahead of Print], PM Barr, A Tedeschi, WG Wierda, JN Allan, P Ghia, D Vallisa, R Jacobs, S O'Brien, AP Grigg, P Walker, C Zhou, J Ninomoto, G Krigsfeld, CS TamFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.